Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial

• Jing Zuo,
• Wei Duan,
• Mingxuan Zhao,
• Zhendong Chen,
• Jie Lin,
• Huaqiu Shi,
• Ou Jiang,
• Youzhong Zhang,
• Meiyu Fang,
• Li Wang,
• Wei Wang,
• Yong Huang,
• Junyan Yu,
• Xiaoxue Zhang,
• Weiqing Pu,
• Deshun Hao,
• Fenglin She,
• Xiugao Yang,
• Ying Chen,
• Qizhi Tang,
• Xiao Zhang,
• Miao Niu,
• Yan'e Song,
• Lingying Wu

Affiliations

Jing Zuo

Department of Gynecology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

Wei Duan

Department of Gynecology and Oncology Beijing Obstetrics and Gynecology Hospital Beijing P. R. China

Mingxuan Zhao

Phase 1 Clinical Trial Center, Anning First People's Hospital Anning Yunnan P. R. China

Zhendong Chen

Department of Oncology The Second Hospital of Anhui Medical University Hefei Anhui P. R. China

Jie Lin

Department of Oncology The Second Affiliated Hospital of Kunming Medical University Kunming Yunnan P. R. China

Huaqiu Shi

Department of Oncology First Affiliated Hospital of Gannan Medical University Ganzhou Jiangxi P. R. China

Ou Jiang

Department of Medical Oncology The Second People's Hospital of Neijiang Neijiang Sichuan P. R. China

Youzhong Zhang

Department of Gynecology Qilu Hospital of Shandong University Jinan Shandong P. R. China

Meiyu Fang

Department of Rare and Head and Neck Oncology Cancer Hospital of The University of Chinese Academy of Sciences Zhejiang Cancer Hospital Hangzhou Zhejiang P. R. China

Li Wang

Department of Gynecology Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University Zhengzhou Henan P. R. China

Wei Wang

Department of Gastroenterology and Urology Hunan Cancer Hospital Changsha Hunan P. R. China

Yong Huang

Department of Oncology The Second People's Hospital of Hefei Hefei Anhui P. R. China

Junyan Yu

Department of Oncology Heping Hospital Affiliated to Changzhi Medical College Changzhi Shanxi P. R. China

Xiaoxue Zhang

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Weiqing Pu

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Deshun Hao

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Fenglin She

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Xiugao Yang

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Ying Chen

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Qizhi Tang

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Xiao Zhang

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Miao Niu

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Yan'e Song

Clinical Development Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang Hebei P. R. China

Lingying Wu

Department of Gynecology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China